ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 692579 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 692579; 2) Community: the network communities that were significantly associated with the response to NSC 692579; 3) Molecule: the relationships between components within communities and NSC 692579; 4) MDR: the compounds that were significantly associated with the NSC 692579.

NSC Compound Enrichment Correlation
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.00921214104936179 0.3280923
NSC 762988 Null 0.00921214104936186 -0.39297783
NSC 287459 Cytarabine AY 0.00921214104936192 0.22031774
NSC 45238 Null 0.00921214104936192 0.46739546
NSC 625350 Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.- hydroxy-, (9,10-dihydro-9,10-dioxo-2-anthracenyl)methyl ester (R*,R*) 0.00921214104936192 -0.29531743
NSC 626164 Discorhabdin C-phenol . TFA 0.00921214104936192 0.29275915
NSC 668296 Null 0.00921214104936192 0.40884471
NSC 688303 Null 0.00921214104936192 0.025019276
NSC 100290 Doxypyrromycin hydrochloride 0.00970780973624031 0.28908191
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 0.00970780973624031 0.34331128
Total:129  Current:32    [First] [Prev] [Next] [Last]